# FDA Inspection 1157720 - Raybow USA Inc. - November 17, 2021

Source: https://www.keypedia.com/records/fda_inspections/raybow-usa-inc/f2fb8812-43dd-44fa-b65e-9baca854a5c5
Source feed: FDA_Inspections

> FDA Inspection 1157720 for Raybow USA Inc. on November 17, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1157720
- Company Name: Raybow USA Inc.
- Inspection Date: 2021-11-17
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 927878 - 2015-05-29](https://www.keypedia.com/records/fda_inspections/raybow-usa-inc/7572cd85-a9b0-46c0-a627-d49b1b75a20b)
- [FDA Inspection 761428 - 2011-11-17](https://www.keypedia.com/records/fda_inspections/raybow-usa-inc/805a2996-6d00-4e75-9d61-846fd1911740)
- [FDA Inspection 620146 - 2009-07-01](https://www.keypedia.com/records/fda_inspections/raybow-usa-inc/26f50615-35f9-4208-baaa-c132cfb4440f)

Company: https://www.keypedia.com/companies/raybow-usa-inc/cb9e77f6-c9e3-42f6-af39-9f4c9492ab4c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c